PBYI - Puma Biotechnology EPS beats by $0.27 beats on revenue February, 20 2020 04:09 PM Puma Biotechnology Inc Puma Biotechnology (NASDAQ:PBYI): Q4 Non-GAAP EPS of $0.01 beats by $0.27; GAAP EPS of -$0.29 beats by $0.19.Revenue of $62.9M (-11.5% Y/Y) beats by $2.94M.Press ReleaseMore news on: Puma Biotechnology, Inc., Earnings news and commentary, Healthcare stocks news,